Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progesterone for recurrent miscarriage: truth and deceptions.

Katharina T Walch1, Johannes C Huber

  • 1Department of Obstetrics and Gynaecology, Division of Gynaecological Endocrinology and Reproductive Medicine, Medical University of Vienna, Waehringer Guertel 18-20, A - 1090 Vienna, Austria. katharina.walch@meduniwien.ac.at

Best Practice & Research. Clinical Obstetrics & Gynaecology
|October 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single nucleotide polymorphisms in gynecological endocrinology.

Expert review of endocrinology & metabolism·2019
Same author

Lymphatic spread of endometriosis to pelvic sentinel lymph nodes: a prospective clinical study.

Fertility and sterility·2011
Same author

Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: cross-sectional study in a Central European district.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2011
Same author

Saliva cortisol levels and subjective stress are not associated with number of oocytes after controlled ovarian hyperstimulation in patients undergoing in vitro fertilization.

Fertility and sterility·2011
Same author

Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals.

The journal of sexual medicine·2011
Same author

A modified technique of laparoscopic ovarian drilling for polycystic ovary syndrome using the monopolar hook electrode.

Acta obstetricia et gynecologica Scandinavica·2011
Same journal

A risk-based classification of late-onset fetal growth disorders according to intrapartum fetal compromise.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

The Cardiac-Fetal-Placental Unit: links between umbilical venous flow and maternal hemodynamics in fetal growth restriction.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Psychosocial interventions for women who are pregnant following a previous reproductive loss: A scoping review.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Controversies in fetal therapy.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Alloimmunisation in pregnancy: current management and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Consensus in prenatal management of Hemolytic disease of the fetus and newborn.

Best practice & research. Clinical obstetrics & gynaecology·2026
See all related articles

Progesterone supplementation may improve pregnancy outcomes for women with recurrent miscarriage, particularly those with unexplained causes. Further research is needed to confirm its efficacy in supporting early pregnancy.

Area of Science:

  • Reproductive Endocrinology
  • Immunology of Pregnancy

Background:

  • Recurrent miscarriage affects 0.5-2% of pregnancies, with no identifiable cause in 50% of cases.
  • Progesterone is crucial for maintaining pregnancy and possesses immunomodulatory properties essential for early gestation.

Purpose of the Study:

  • To evaluate the potential benefits of progestogen treatment for women experiencing recurrent miscarriage.
  • To explore progesterone's role as an immunomodulatory agent in early pregnancy.

Main Methods:

  • Review of existing evidence on progestogen supplementation in recurrent miscarriage.
  • Analysis of progesterone's effects on growth factors, cytokines, and decidual proteins.

Main Results:

  • Evidence suggests progestogen treatment may improve pregnancy outcomes in women with recurrent miscarriage.

Related Experiment Videos

  • Progesterone influences key molecular pathways involved in successful implantation and gestation.

    • Conclusions:

    • Women with idiopathic recurrent miscarriage may benefit from progestogen therapy.
    • Further high-powered studies are necessary to establish the definitive efficacy of progestogen treatment for recurrent miscarriage.